About the journal

A peer-reviewed, online, open access journal, Antibody Therapeutics provides a forum for the publication of the latest advances and challenges in the discovery, research, development, manufacturing, and methodology of therapeutic antibodies for the global scientific community. Topics include target and antibody discovery, mechanistic research, new technologies and methods, manufacturing, clinical trials, regulation, policies, and more. Antibody Therapeutics article types include original research, reviews, cutting-edge technologies, new methods, news, interviews, and meeting highlights.

Journal metrics

Citation metrics
Clarivate
2025 Impact Factor 4.8
Scopus
2025 CiteScore 7.8
Immunology And Allergy (Rank by CiteScore) 57/234
Immunology (Rank by CiteScore) 62/243
2025 Source Normalized Impact per Paper (SNIP) 1.092
Readership
2025 Full Text Usage 207,842
Peer Review and Production
2025 Median days from submission to first decision 30 days
2025 Median days from submission to final decision 66 days

Disclaimer

Statements of fact and opinion in the articles in Antibody Therapeutics are those of the respective authors and contributors and not of the Journal, ChAbS, or Oxford University Press, unless otherwise expressly indicated. Neither Oxford University Press, ChAbS, nor the Journal make any representation, express or implied, in respect of the accuracy of the material in the Journal and cannot accept any legal responsibility or liability for any errors or omissions that may be made. Readers should make their own evaluation as to the appropriateness or otherwise of the information included.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Please sign in to your personal account to gift article access.

Gift article access

Please create a link below to share with others. This will provide temporary access to this restricted article.

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses.

You have reached the limit of 10 links within a 30 day period